- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05956912
Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
Background: Cardiac rehabilitation (CR) services aim to improve heart disease patients' health and quality of life and reduce the risk of further cardiac events. Depression and anxiety are common among CR patients, and current psychological treatments for cardiac patients have minor effects. However, the NIHR-funded PATHWAY trial found that group Metacognitive Therapy (MCT) was associated with improvements in anxiety and depression when added to CR and was more effective than usual CR alone. Group MCT was also associated with preventing anxiety and depression. The next steps will establish beacon sites for delivering MCT and pilot-test additions to the national audit of cardiac rehabilitation (NACR) data capture mechanism to include an MCT data field. Such steps will support a quantitative and qualitative evaluation of implementation.
Methods: The investigators aim to address questions concerning the quality of patient data recorded, level of adoption at sites, the characteristics of patients attending MCT, the impact of adding MCT to CR on mental health outcomes, and patient, healthcare staff and commissioner views of barriers/enablers to implementation. The investigators will deliver training in group MCT to CR staff from CR services across England. The investigators will conduct semi-structured qualitative interviews with CR staff trained in group MCT to assess views on the training programme, including successes and barriers to implementation of training and delivery. The investigators will interview 8-10 CR stakeholders to identify any barriers to implementation and how these might be resolved.
Discussion: The study will support development of an NHS roll-out strategy and systematic data collection that can be used to evaluate wide-scale implementation. The study can benefit service users by improving patients' mental health outcomes and CR practitioners' clinical skills. Results will be disseminated via peer-reviewed journals, national and international conferences and service user/voluntary sector organisations and networks.
Study Overview
Status
Conditions
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Adrian Wells, PhD
- Phone Number: 01612765399
- Email: adrian.wells@manchester.ac.uk
Study Contact Backup
- Name: Lora Capobianco, PhD
- Phone Number: 01610046664
- Email: lora.capobianco@gmmh.nhs.uk
Study Locations
-
-
-
Manchester, United Kingdom, M13 9WL
- Recruiting
- Manchester University NHS Foundation Trust
-
Contact:
- Lora Capobianco, PhD
- Email: Lora.capobianco@gmmh.nhs.uk
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Cardiac rehabilitation staff trained in delivering Group-MCT, wider cardiac rehabilitation staff and managers, and healthcare professionals from local clinical commissioning groups.
All CR patients attending cardiac rehabilitation.
Description
Qualitative Inclusion Criteria:
All CR staff must meet the following inclusion criteria to be eligible:
- Be a healthcare professional working with cardiac rehabilitation services being trained to deliver group-MCT
- Be a healthcare professional working with cardiac rehabilitation or be a professional working at the commissioner level
- Minimum of 18 years old
- Competent level of English Language skills (able to read, understand and complete interviews in English).
Exclusion Criteria:
- Below 18 years of age
- Not a healthcare professional or professional working at the commissioner level
- Does not have a competent level of English language skills
Audit inclusion criteria:
All patients attending CR who meet the NICE recommendations for acute coronary syndrome (NG185) and heart failure (NG106) will be offered group MCT as part of routine CR.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Adoption of group MCT
Time Frame: Within the 6 months that MCT is being delivered in CR services
|
Successful adoption of group MCT at each site is set a-priori. A traffic-light criteria will be used to determine successful adoption.
A Green rating indicates that a site has fully met the criteria for successful adoption. Red indicates a failure to meet the requirements. Amber is partial adoption, where amendments to procedures and protocols might lead to successful adoption. At Amber sites, specific qualitative work will be undertaken to understand the reasons for not meeting criteria more fully and to help develop strategies to ameliorate this. An overall assessment will be made considering the traffic-light ratings of all six beacon sites. |
Within the 6 months that MCT is being delivered in CR services
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Dartmouth Coop
Time Frame: Initial Cardiac Rehabilitation Assessment (Baseline) & Within 6 months of attending cardiac rehabilitation (Discharge)
|
The COOP will be captured through the National Audit for Cardiac Rehabilitation.
It is a self-report measure designed to evaluate the functional abilities of medical patients.
It consists of nine items covering various areas such as physical function, daily activities, pain, social activities, social support, emotions, overall health, changes in health, and quality of life.
Each chart includes text and illustrations to assist the user in responding.
The responses are graded on an ordinal scale of 1 to 5, with one being the best score.
|
Initial Cardiac Rehabilitation Assessment (Baseline) & Within 6 months of attending cardiac rehabilitation (Discharge)
|
|
Semi-structured interviews will explore the views and opinions of group-MCT in CR (CR staff trained in group-MCT)
Time Frame: 1 month prior to training in MCT
|
To understand what CR staff views of training in group MCT are with a view to understanding enablers and barriers.
To understand the consequences, both expected and unexpected, of implementing group-MCT, for example on existing CR services, staffing needs, administration and resource requirements.
|
1 month prior to training in MCT
|
|
Semi-structured interviews will explore the views and opinions of group-MCT in CR (CR staff trained in group-MCT)
Time Frame: Within 1 month of delivering the pilot group of MCT
|
To understand what CR staff views of training in group MCT are with a view to understanding enablers and barriers.
To understand the consequences, both expected and unexpected, of implementing group-MCT, for example on existing CR services, staffing needs, administration and resource requirements.
|
Within 1 month of delivering the pilot group of MCT
|
|
Semi-structured interviews will explore the views and opinions of group-MCT in CR (CR staff trained in group-MCT)
Time Frame: Upon completion of delivering group-MCT, approximately 5 months after starting the delivery of MCT in CR
|
To understand what CR staff views of training in group MCT are with a view to understanding enablers and barriers.
To understand the consequences, both expected and unexpected, of implementing group-MCT, for example on existing CR services, staffing needs, administration and resource requirements.
|
Upon completion of delivering group-MCT, approximately 5 months after starting the delivery of MCT in CR
|
|
Semi-structured interviews will explore the views and opinions of group-MCT in CR (CCG and other management stakeholders)
Time Frame: Through implementation of MCT in CR services, approximately 7 months.
|
To understand the acceptability and feasibility of roll-out at commissioner level and what the enablers or barriers are.
To understand the consequences, both expected and unexpected, of implementing group-MCT, for example on existing CR services, staffing needs, administration and resource requirements.
|
Through implementation of MCT in CR services, approximately 7 months.
|
|
Hospital Anxiety and Depression Scale (HADS)
Time Frame: Initial Cardiac Rehabilitation Assessment (Baseline) & Within 6 months of attending cardiac rehabilitation (Discharge)
|
The HADS will be captured through the National Audit for Cardiac Rehabilitation.
It is a 14-item self-report questionnaire that measures symptoms of anxiety (7 items) and depression (7 items).
Items are rated using a 4-point (0-3) scale, with higher scores indicating elevated distress.
Scores for each subscale range from 0 to 21 and can be categorised as normal (0-7), mild (8-10), moderate (11-14), or severe (15-21).
|
Initial Cardiac Rehabilitation Assessment (Baseline) & Within 6 months of attending cardiac rehabilitation (Discharge)
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Adrian Wells, PhD, University of Manchester
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRAS ID: 313677
- 29567 (Other Grant/Funding Number: NIHR)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
Massachusetts General HospitalRecruitingDepression | Depression - Major Depressive Disorder | Depression Chronic | Depression in Adults | Depression Disorders | Depression DisorderUnited States
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Active, not recruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
ProgenaBiomeWithdrawnDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Sorlandet Hospital HFUniversity of Oslo; Karolinska Institutet; Australian Catholic University; Helse...RecruitingAnxiety | Anxiety Depression | Depression Anxiety Disorder | Depression - Major Depressive DisorderNorway
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Lipocine Inc.CompletedDepression, Postpartum | Postnatal Depression | Peripartum Depression | Depression, Post-Partum | Postpartum Depression (PPD) | Post-Natal DepressionUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Kolby Walker, DO; Brittany KimbleRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryActive, not recruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of MinnesotaCompletedDepression SymptomsUnited States
-
University of CincinnatiNational Center for Complementary and Integrative Health (NCCIH)RecruitingMild DepressionUnited States